Johnson & Johnson Surgical Vision India Profile
Key Indicators
- Authorised Capital ₹ 4.72 Cr
as on 31-07-2024
- Paid Up Capital ₹ 4.19 Cr
as on 31-07-2024
- Company Age 20 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 35.57%
(FY 2023)
- Profit 182.89%
(FY 2023)
- Ebitda 116.46%
(FY 2023)
- Net Worth 12.70%
(FY 2023)
- Total Assets 24.45%
(FY 2023)
About Johnson & Johnson Surgical Vision India
The Corporate was formerly known as Advanced Medical Optics India Private Limited. The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 4.72 Cr and a paid-up capital of Rs 4.19 Cr, as per Ministry of Corporate Affairs (MCA) records.
Burzin Shahana, Surjeet Lamba, and Rohit Gulati serve as directors at the Company.
- CIN/LLPIN
U24231KA2004PTC034235
- Company No.
034235
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Jun 2004
- Date of AGM
29 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Bangalore
Industry
Company Details
- Location
Bangalore South, Karnataka, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Johnson & Johnson Surgical Vision India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Burzin Shahana  | Director | 24-Aug-2015 | Current |
| Surjeet Lamba | Additional Director | 24-Apr-2024 | Current |
| Rohit Gulati | Additional Director | 24-Apr-2024 | Current |
Financial Performance and Corporate Structure Insights of Johnson & Johnson Surgical Vision India.
Johnson & Johnson Surgical Vision India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 35.57% increase. The company also saw a substantial improvement in profitability, with a 182.89% increase in profit. The company's net worth Soared by an impressive increase of 12.7%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Johnson & Johnson Surgical Vision India?
In 2023, Johnson & Johnson Surgical Vision India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Johnson & Johnson Surgical Vision India?
Johnson & Johnson Surgical Vision India has a workforce of 198 employees as of Mar 29, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Johnson & Johnson Surgical Vision India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Johnson & Johnson Surgical Vision India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
